Dasatinib in breast cancer: Src-ing for response in all the wrong kinases

Ann Transl Med. 2018 Nov;6(Suppl 1):S60. doi: 10.21037/atm.2018.10.26.
No abstract available

Publication types

  • Editorial
  • Comment